AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17083652
Drug: 25 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 microg of vaginal misoprostol with sublingual placebo (n = 70)
Trial: 15684166
Drug: 50 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 microg of sublingual misoprostol
Trial: 15313947
Drug: Xuezhikang 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang 1200 mg/d
Trial: 8935811
Drug: Amisulpride (630-910
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (630-910 mg/day)
Trial: 8935811
Drug: Amisulpride (1100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (1100 mg/day)
Trial: 1589668
Drug: Amoxicillin 750
RxNorm normalized name: amoxicillin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 750 mg b.i.d. for 7 days
Trial: 12203058
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid mixture, group H (3.45 +/- 0.07 g/kg per day)
Trial: 12203058
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid mixture, group M (2.59 +/- 0.07 g/kg per day)
Trial: 12203058
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid mixture, group L (1.72 +/- 0.06 g/kg per day)
Trial: 8910647
Drug: Ultrasensitive enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasensitive enzyme immunoassay for simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase of HIV-1
Trial: 8910647
Drug: Conventional methods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional methods for HIV-1 antibody detection
Trial: 8478300
Drug: Dirithromycin 500
RxNorm normalized name: Dirithromycin
DrugBank: Dirithromycin (DB00954)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dirithromycin 500 mg once daily (od)
Trial: 8478300
Drug: Miocamycin 600
RxNorm normalized name: miocamycin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miocamycin 600 mg twice daily (bd)
Trial: 3515921
Drug: Flurbiprofen 100
RxNorm normalized name: flurbiprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 100 mg BID (twice daily)
Trial: 3515921
Drug: Flurbiprofen 50
RxNorm normalized name: flurbiprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 50 mg QID (four times daily)
Trial: 3515921
Drug: Flurbiprofen treatment
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen treatment (both regimens)
Trial: 29553418
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg preservative-free morphine
Trial: 29553418
Drug: 20 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 μg fentanyl
Trial: 29058837
Drug: Oxycodone (Oxynorm®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (Oxynorm® instant)
Trial: 24159772
Drug: Prostatotropic drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostatotropic drug Vitaprost along with comprehensive treatment including preoperative trophic and flebotonic therapy, laparoscopic surgical clipping of the internal spermatic vein, and post-operative rehabilitation.
Trial: 24159772
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment including preoperative trophic and flebotonic therapy, laparoscopic surgical clipping of the internal spermatic vein, and post-operative rehabilitation without Vitaprost.
Trial: 21495322
Drug: Chlorhexidine digluconat
RxNorm normalized name: Chlorhexidine digluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine digluconat 0.2% for mouthrinsing twice a day
Trial: 21495322
Drug: NaF 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaF 0.05% for mouthrinsing twice a day
Trial: 9686089
Drug: Sufentanil group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil group (0.2 mg.kg‐1 sufentanil added to 0.5% bupivacaine 1 mg.kg‐1 and 1% lidocaine 2 mg.kg‐1)
Trial: 9686089
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.5% bupivacaine 1 mg.kg‐1 and 1% lidocaine 2 mg.kg‐1)
Trial: 22634908
Drug: Group MC
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group MC - morphine 0.1 mg/ml and clonidine 5 μg/ml continuously infused at 5 ml/h
Trial: 22634908
Drug: Group BM
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group BM - bupivacaine 0.125% and morphine 0.1 mg/ml
Trial: 22634908
Drug: Group BC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group BC - bupivacaine 0.125% and clonidine 5 μg/ml
Trial: 22634908
Drug: Group MC
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group MC - morphine 0.1 mg/ml and clonidine 5 μg/ml
Trial: 10230950
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 g administered 30 minutes before CPB)
Trial: 9783757
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg slow release
Trial: 8628979
Drug: Naproxen 750-1000
RxNorm normalized name: naproxen 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 750-1000 mg
Trial: 6118170
Drug: Brompheniramine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brompheniramine (12 mg)
Trial: 6118170
Drug: Carbinoxamine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbinoxamine (12 mg)
Trial: 6351890
Drug: Clemastine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine (1 mg)
Trial: 6118170
Drug: Phenylpropanolamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylpropanolamine (50 mg)
Trial: 31087200
Drug: Nivolumab (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab (3 mg/kg) every 2 weeks until disease progression or toxicity requiring study discontinuation
Trial: 11752122
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of MDMA plus 0.8 g/kg ethanol
Trial: 11752122
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of MDMA
Trial: 24838369
Drug: 0.8 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 g/kg of ethanol
Trial: 9615259
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg om
Trial: 9615259
Drug: omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 10 mg om
Trial: 3549473
Drug: ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150 mg bd
Trial: 882110
Drug: Penicillin G
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin G administered intravenously every four hours for a total of 50,000 U per kilogram per day
Trial: 31512830
Drug: Acid etching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acid etching with 98% concentrated sulfuric acid for 60, 120, and 300 s (groups E, F, G)
Trial: 31512830
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group H (no surface treatment)
Trial: 26016146
Drug: Palliative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palliative radiotherapy course with a fractional dose of 3 Gy to 42 Gy SOD (SDeq 51 Gy) in group 1 (20 patients)
Trial: 26016146
Drug: Radiotherapy using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy using dynamic dose fractionation: fractional doses of 4, 3, and 2 Gy to 51 Gy SDeq in group 2 (20 patients)
Trial: 26016146
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment using dynamic dose fractionation: fractional doses of 4, 3, and 2 Gy to 56 Gy SDeq and chemotherapy (Xeloda or ftorafur) in group 3 (20 patients)
Trial: 23167953
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg vitamin C
Trial: 21706269
Drug: Vascular endothelial
RxNorm normalized name: Vascular endothelial growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vascular endothelial growth factor receptor-2 (VEGFR-2) expression in malignant cases
Trial: 16567439
Drug: SonoVue contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SonoVue contrast agent administration
Trial: 10781116
Drug: Mivacurium 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.04 mg.kg‐1
Trial: 8640163
Drug: Sequential IL-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential IL-3 -> G-CSF (Arm 2)
Trial: 8640163
Drug: Sequential IL-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential IL-3 -> GM-CSF (Arm 3)
Trial: 8640163
Drug: Combined IL-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined IL-3 + G-CSF (Arm 4)
Trial: 8640163
Drug: GM-CSF after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF after PBSC infusion
Trial: 1451712
Drug: ibuprofen-codeine 200
RxNorm normalized name: codeine / ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen-codeine 200 mg : 30 mg
Trial: 1451712
Drug: acetylsalicylic acid-codeine
RxNorm normalized name: codeine and acetylsalicylic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acetylsalicylic acid-codeine 500 mg : 30 mg
Trial: 1451712
Drug: codeine 30
RxNorm normalized name: codeine 30 MG
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: codeine 30 mg
Trial: 22451451
Drug: Valsartan (80-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80-160 mg per day)
Trial: 22451451
Drug: Non-RAS inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-RAS inhibitor treatment
Trial: 19121416
Drug: Zoledronate 4
RxNorm normalized name: zoledronic acid 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoledronate 4 mg
Trial: 15207898
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg per day)
Trial: 11830920
Drug: Tamoxifen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen plus CMF (C 500 mg/m2, M 40 mg/m2, F 600 mg/m2 on days 1st and 8th q 28 day for 6 cycles)
Trial: 9552047
Drug: Adjuvant interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant interferon alfa-2a treatment (3 mIU subcutaneously daily for 3 weeks, then 3 mIU three times per week for 1 year)
Trial: 7917369
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose carboplatin (30 mg/m2 on days 1-5, weeks 1, 3, 5, and 7)
Trial: 7917369
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose carboplatin (up to 55 mg/m2)
Trial: 7917369
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose carboplatin and radiotherapy (70 Gy)
Trial: 7917369
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose carboplatin and radiotherapy (40-45 mg/m2)
Trial: 7917369
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose carboplatin and radiotherapy
Trial: 31977865
Drug: Afatinib 40
RxNorm normalized name: afatinib 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Afatinib 40 mg/day plus HAD-B1 972 mg
Trial: 31977865
Drug: Afatinib 40
RxNorm normalized name: afatinib 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Afatinib 40 mg/day plus HAD-B1 1944 mg
Trial: 29457215
Drug: Inhalational agent-opioid
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalational agent-opioid anaesthesia
Trial: 23921860
Drug: Lidocaine submucosal
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine submucosal injection (1.8 mL of 2% lidocaine with 1:100,000 epinephrine)
Trial: 23921860
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (four puffs of 10% lidocaine)
Trial: 21751432
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate 50/100 µg bd (SFC)
Trial: 21751432
Drug: Montelukast 5
RxNorm normalized name: montelukast 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 5 mg od (MON)
Trial: 18154127
Drug: Dicarbamin 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dicarbamin 100 mg/day
Trial: 18154127
Drug: ABVD chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABVD chemotherapy plus dicarbamin
Trial: 9684947
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of hypericum extract with 5.0% hyperforin, once a day for 8 days
Trial: 9684947
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of hypericum extract with 0.5% hyperforin, once a day for 8 days
Trial: 2736988
Drug: EACA (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EACA (5 g prior to skin incision, followed by 1 g/h for 6 to 8 h)
Trial: 2736988
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline solution administered in the same fashion)
Trial: 29281101
Drug: Sildenafil (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (40 mg three times daily)
Trial: 18326282
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg a day for 4 months
Trial: 18326282
Drug: Losartan in
RxNorm normalized name: Product containing losartan in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan in combination with non-drug means
Trial: 16585984
Drug: 308-nm UVB
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 308-nm UVB therapy
Trial: 16585984
Drug: cream PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cream PUVA therapy
Trial: 6133544
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg temazepam
Trial: 24867068
Drug: DHEA 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 75 mg once a day for 8 weeks before and during IVF treatment
Trial: 19803239
Drug: Needle‐sticking method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle‐sticking method combined with single‐finger meditation pushing therapy at pain points
Trial: 16409461
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 2.5 mg b.i.d.
Trial: 16409461
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 5 mg b.i.d.
Trial: 16409461
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 10 mg b.i.d.
Trial: 16409461
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 20 mg b.i.d.
Trial: 16409461
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 30 mg b.i.d.
Trial: 16409461
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg once daily (control)
Trial: 16241946
Drug: BAY 59-7939
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 59-7939 (all doses)
Trial: 11751721
Drug: Propranolol (0.21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.21 mg/kg total intravenous dose in 15 minutes)
Trial: 9480620
Drug: Betadine vaginal
RxNorm normalized name: Betadine Vaginal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betadine vaginal suppository (200 mg polyvidonum‐iodine PVP) for 7 days
Trial: 7685895
Drug: Steroid-eluting lead
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-eluting lead
Trial: 3327654
Drug: diet plus
RxNorm normalized name: Glucomannan/Grapefruit Extract/Pyridoxine Oral Tablet [GRAPEFRUIT DIET PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diet plus drug (colestipol plus niacin)
Trial: 31604475
Drug: lacosamide (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lacosamide (up to 400 mg/day)
Trial: 17688642
Drug: DTPa‐HBV‐IPV vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa‐HBV‐IPV vaccine
Trial: 12392812
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (untreated participants in wait-list, no-treatment, and placebo conditions)
Trial: 8184493
Drug: Intravesical Bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for carcinoma in situ (CIS)
Trial: 8184493
Drug: Intravesical Bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for prophylaxis
Trial: 8184493
Drug: Intravesical Bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical Bacillus Calmette‐Guérin (BCG) treatment for tumor(s)
Trial: 2684039
Drug: Daily 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily 6-mercaptopurine and weekly methotrexate (neutropenic group)
Trial: 2684039
Drug: Daily 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily 6-mercaptopurine and weekly methotrexate (non-neutropenic group)
Trial: 1093670
Drug: Diethylstilbestrol 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylstilbestrol 5.0 mg/day
Trial: 1093670
Drug: Diethylstilbestrol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylstilbestrol 1.0 mg/day
Trial: 1093670
Drug: Early endocrine
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early endocrine treatment
Trial: 26313133
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical treatment for ACS (N=123)
Trial: 22379905
Drug: Sevoflurane and
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane and extended-release epidural anesthesia with Ropivacaine 0.3%
Trial: 25994838
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg once daily
Trial: 15475417
Drug: Treatment regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment regimen 1
Trial: 15475417
Drug: Treatment regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment regimen 2
Trial: 10600077
Drug: Atraumatic restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic restorative treatment (ART) using hand instruments
Trial: 8757381
Drug: Ibuprofen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (500 mg suppositories administered 12 and 2 hours before surgery, and every 8 hours until the third postoperative day)
Trial: 8757381
Drug: Ibuprofen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (500 mg suppositories)
Trial: 8757381
Drug: Placebo (suppositories
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (suppositories administered 12 and 2 hours before surgery, and every 8 hours until the third postoperative day)
Trial: 6807681
Drug: Oxprenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (100 mg) for 24 hours
Trial: 6807681
Drug: Indomethacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (200 mg) for 24 hours
Trial: 6807681
Drug: Oxprenolol +
RxNorm normalized name: oxprenolol
DrugBank: Oxprenolol (DB01580)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxprenolol + Indomethacin (100 + 200 mg) for 24 hours
Trial: 22990854
Drug: L. reuteri
RxNorm normalized name: L. reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. reuteri NCIMB 30242 capsules
Trial: 20486914
Drug: Mycophenolate therapy
RxNorm normalized name: mycophenolate
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mycophenolate therapy
Trial: 11777716
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine ophthalmic solution 0.5%
Trial: 8625175
Drug: Sho-saiko-to (TJ-9)
RxNorm normalized name: erlotinib
DrugBank: Erlotinib (DB00530)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sho-saiko-to (TJ-9) at a daily oral dose of 7.5 g
Trial: 8625175
Drug: Conventional drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drugs (Control)
Trial: 31241992
Drug: Spironolactone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50 mg and 100 mg)
Trial: 25491792
Drug: JNJ‐39758979 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐39758979 100 mg
Trial: 25491792
Drug: JNJ‐39758979 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐39758979 300 mg